EMPLOYMENT AGREEMENTEmployment Agreement • May 9th, 2024 • HOOKIPA Pharma Inc. • Pharmaceutical preparations
Contract Type FiledMay 9th, 2024 Company IndustryThis Employment Agreement (“Agreement”) is made between HOOKIPA Biotech GmbH (the “Company”), and Mark Winderlich (the “Executive”) and is made effective as of June 1, 2024 (the “Effective Date”).
MUTUAL TERMINATION AGREEMENTMutual Termination Agreement • May 9th, 2024 • HOOKIPA Pharma Inc. • Pharmaceutical preparations
Contract Type FiledMay 9th, 2024 Company IndustryTHIS MUTUAL TERMINATION AGREEMENT is made this March 31, 2024 (the “Effective Date”), by and between Hookipa Biotech GmbH, an Austrian corporation, having its principal place of business at St Marx Vienna BioCenter: Helmut-Qualtinger-Gasse 2, 1030 Vienna, Austria ("HOOKIPA"), and Malte Peters, M.D., having its principal place of business at [ADDRESS] (“CONSULTANT”), (each Party hereinafter referred to as a “Party” and both Parties collectively referred to as the “Parties”).
AMENDMENT NO. 1 TO THE EMPLOYMENT AGREEMENTEmployment Agreement • May 9th, 2024 • HOOKIPA Pharma Inc. • Pharmaceutical preparations
Contract Type FiledMay 9th, 2024 Company IndustryThis Amendment No. 1 (“Amendment”) is a modification of the Employment Agreement by and between HOOKIPA Biotech GmbH (the “Company”), and Mark Winderlich, PhD MSc (the “Executive”), effective as of June 1, 2024 (“Agreement”).